Waters Corporation (NYSE: WAT) and IMU Biosciences have formed a strategic partnership to advance an AI-powered immune ...
IMU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a ...
IMU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time.Waters Biosciences' technologies ...
Altering a single gene in human embryonic cells has revealed that NANOG plays a key role in early embryo development, ...
The Biognosys Group, a leader in mass spectrometry-based multiomics, announces advancements across its integrated multiomics ...
Interferon receptor knockout chickens uncover how type I and III interferons differentially shape avian antiviral immunity and influenza disease outcomes.
A newly developed open-source tool designed for rigorous reanalysis of genomic data is highly effective at detecting new rare disease diagnoses. The tool's ability to frequently and automatically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results